PULM today
$1.29+$0.02 (+1.57%)close Nov 13, 2026Trend
DailyDowntrend (confirmed)
4 hourDescending Triangle
1 hourLeaning Bullish
15 minBullish
5 minConsolidating
Daily trend turns up above $2.28
Key levels
Resistance$1.61
Resistance$1.34
Support$1.16
Latest news & SEC filings
ProductEos SENOLYTIX releases early-stage study results for PTC-2105
ProductEos SENOLYTIX says PTC-2105 helped aged rats keep motor skills and lose body fat
All PULM news →About Pulmatrix
Pulmatrix is a biopharmaceutical company that develops inhaled therapeutic products using its iSPERSE dry powder delivery technology. Its pipeline includes candidates for acute migraine, chronic obstructive pulmonary disease exacerbations, and allergic bronchopulmonary aspergillosis. The company is based in the United States and has paused development of its product candidates while pursuing a merger and seeking to monetize its assets.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Healthcare
Pulmatrix, Inc. (PULM)
What Is the Price Target for PULM?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is PULM a Buy or Sell Right Now?
Thesis
- •Revenue growing 7.0% YoY with UNKNOWN trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for PULM.
Start Free Trial →Is PULM Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/B
Fair Value
$1.50
17
Moat Score
NONE
3/9
Piotroski Score
-94.8
Altman Z-Score
What Is Smart Money Doing with PULM?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →PULM Growth Story
Revenue YoY
7.0%
3yr Revenue CAGR
N/A%
EPS Growth YoY
46.18%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for PULM
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for PULM, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:05:59 | $1.24 | 1,000 | $$1K | BUY |
| 20:05:49 | $1.24 | 1,000 | $$1K | BUY |
| 15:03:19 | $1.33 | 1,110 | $$1K | BUY |
| 20:46:00 | $1.28 | 1,872 | $$2K | BUY |
| 15:37:21 | $1.37 | 1,195 | $$2K | SELL |
5 dark pool trades shown · $$8K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Pulmatrix, Inc. (PULM) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →PULM — frequently asked questions
What is PULM stock price today?
Pulmatrix, Inc. (PULM) is at $1.29, up 1.57% (+$0.02) at the Nov 13, 2026 close.
Why is PULM stock moving today?
Latest PULM news — Nov 11, 2026: Eos SENOLYTIX releases early-stage study results for PTC-2105 · Oct 30, 2026: Eos SENOLYTIX says PTC-2105 helped aged rats keep motor skills and lose body fat
Did PULM beat earnings?
PULM last reported on Aug 13, 2026: EPS -$0.29 vs -$2.00 expected — a beat of 85.5%.
What are PULM support and resistance levels?
Support: $1.16. Resistance: $1.34, $1.61, $1.78.
What are insiders doing with PULM?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on PULM?
Nov 11, 2026: Eos SENOLYTIX releases early-stage study results for PTC-2105 · Oct 30, 2026: Eos SENOLYTIX says PTC-2105 helped aged rats keep motor skills and lose body fat